Ketamine, a medication commonly used for pain relief and increasingly used for depression, may help alleviate migraine pain in patients who have not been helped by other treatments, suggests a study being presented at the ANESTHESIOLOGY® 2017 annual meeting. The study of 61 patients found that almost 75 percent experienced an improvement in their migraine intensity after a three- to seven-day course of inpatient treatment with ketamine.
Become a Member!
– All SoP monthly magazines
– All NPT magazine archives (63 issues)
– Assorted reading and video courses
– Discounts and access to select webinars and special events
*All pricing in USD.